Bionano Genomics (BNGO) Change in Acquisitions & Divestments (2021 - 2026)

Bionano Genomics has disclosed Change in Acquisitions & Divestments across 6 years of filings, most recently posting $54.1 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $54.1 million, up 6.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $232.6 million (up 16.57% YoY), and the FY2025 annual result was $229.1 million, down 25.36% from the prior year.
• Change in Acquisitions & Divestments came in at $54.1 million for Q1 2026 at Bionano Genomics, down from $68.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $158.2 million in Q1 2024 to a low of $16.9 million in Q1 2023.
• The 5-year median for Change in Acquisitions & Divestments is $52.2 million (2023), against an average of $54.6 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 836.58% in 2024 and sank 67.95% in 2025, its largest moves.
• Bionano Genomics' Change in Acquisitions & Divestments stood at $65.5 million in 2022, then fell by 20.38% to $52.2 million in 2023, then tumbled by 58.4% to $21.7 million in 2024, then surged by 215.1% to $68.4 million in 2025, then fell by 20.82% to $54.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $54.1 million (Q1 2026), $68.4 million (Q4 2025), and $56.2 million (Q3 2025), per Business Quant data.